{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:32:27Z","timestamp":1781019147448,"version":"3.54.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DK07780"],"award-info":[{"award-number":["T32DK07780"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.clml.2023.05.012","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T02:49:04Z","timestamp":1684810144000},"page":"642-650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas"],"prefix":"10.1016","volume":"23","author":[{"given":"Rahul S.","family":"Bhansali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3280-5271","authenticated-orcid":false,"given":"Stefan K.","family":"Barta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clml.2023.05.012_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"25","key":"10.1016\/j.clml.2023.05.012_bib0002","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International Peripheral T-cell and Natural Killer\/T-Cell Lymphoma Study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.clml.2023.05.012_bib0003","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3324\/haematol.2017.186577","article-title":"The outcome of peripheral T-Cell Lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project","volume":"103","author":"Bellei","year":"2018","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.clml.2023.05.012_bib0004","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.clml.2023.05.012_bib0005","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.clml.2023.05.012_bib0006","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":"Treatment and prognosis of mature T-cell and NK-Cell Lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.clml.2023.05.012_bib0007","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2014-04-573089","article-title":"Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry","volume":"124","author":"Ellin","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clml.2023.05.012_bib0008","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.annonc.2021.12.002","article-title":"The ECHELON-2 Trial: 5-year results of a randomized, phase III study of Brentuximab Vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma","volume":"33","author":"Horwitz","year":"2022","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.clml.2023.05.012_bib0009","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/gut.3.3.232","article-title":"Intestinal reticulosis as a complication of idiopathic steatorrhoea","volume":"3","author":"Gough","year":"1962","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.clml.2023.05.012_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1703","article-title":"Gastrointestinal lymphoma: where morphology meets molecular biology","volume":"205","author":"Isaacson","year":"2005","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.clml.2023.05.012_bib0011","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center","volume":"18","author":"Gale","year":"2000","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clml.2023.05.012_bib0012","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0609.2005.00495.x","article-title":"Clinicopathological analysis of T-cell lymphoma in Taiwan according to WHO classification: high incidence of enteropathy-type intestinal T-cell lymphoma","volume":"75","author":"Lee","year":"2005","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.clml.2023.05.012_bib0013","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0002-9440(10)65736-7","article-title":"Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology","volume":"153","author":"Chott","year":"1998","journal-title":"Am J Pathol"},{"issue":"9225","key":"10.1016\/j.clml.2023.05.012_bib0014","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac disease study group","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clml.2023.05.012_bib0015","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0016-5085(03)01047-3","article-title":"Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease","volume":"125","author":"Mention","year":"2003","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clml.2023.05.012_bib0016","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.2005.068684","article-title":"Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease","volume":"55","author":"Di Sabatino","year":"2006","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.clml.2023.05.012_bib0017","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1172\/JCI41344","article-title":"IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis","volume":"120","author":"Malamut","year":"2010","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.clml.2023.05.012_bib0018","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clml.2023.05.012_bib0019","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","article-title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project","volume":"118","author":"Delabie","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.clml.2023.05.012_bib0020","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gut.2006.114512","article-title":"Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience","volume":"56","author":"Al-Toma","year":"2007","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.clml.2023.05.012_bib0021","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","article-title":"Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study","volume":"45","author":"Malamut","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"11","key":"10.1016\/j.clml.2023.05.012_bib0022","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/00365520802240222","article-title":"Incidence of enteropathy\u2013associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands","volume":"43","author":"Verbeek","year":"2008","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"10.1016\/j.clml.2023.05.012_bib0023","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/leu.2016.178","article-title":"Mutations in the JAK\/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas","volume":"30","author":"Nicolae","year":"2016","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.clml.2023.05.012_bib0024","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1182\/blood-2011-10-385559","article-title":"How I treat enteropathy-associated T-cell lymphoma","volume":"119","author":"Di Sabatino","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2023.05.012_bib0025","first-page":"191","article-title":"A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin's lymphomas","volume":"16","author":"Novakovic","year":"2006","journal-title":"Oncol Rep"},{"issue":"2","key":"10.1016\/j.clml.2023.05.012_bib0026","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.25674","article-title":"Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas","volume":"95","author":"Foss","year":"2020","journal-title":"Am J Hematol"},{"issue":"13","key":"10.1016\/j.clml.2023.05.012_bib0027","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1158\/1078-0432.CCR-14-2195","article-title":"A new and validated clinical prognostic model (EPI) for enteropathy-associated T-cell lymphoma","volume":"21","author":"de Baaij","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.clml.2023.05.012_bib0028","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000478-199305000-00001","article-title":"Primary lymphoma of the small intestine. A clinicopathological study of 119 cases","volume":"17","author":"Domizio","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.clml.2023.05.012_bib0029","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/10245332.2017.1335979","article-title":"Positron emission tomography computed tomography features of monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"23","author":"Chan","year":"2018","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.clml.2023.05.012_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mpdhp.2020.11.001","article-title":"Primary gastrointestinal T-cell lymphomas: concepts and diagnostic insights","volume":"27","author":"Lesmes","year":"2021","journal-title":"Diagnost Histopathol"},{"issue":"9381","key":"10.1016\/j.clml.2023.05.012_bib0031","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(03)14027-5","article-title":"Coeliac disease","volume":"362","author":"Green","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clml.2023.05.012_bib0032","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cgh.2005.12.011","article-title":"Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.clml.2023.05.012_bib0033","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20160894","article-title":"Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2","volume":"214","author":"Moffitt","year":"2017","journal-title":"J Exp Med"},{"issue":"19","key":"10.1016\/j.clml.2023.05.012_bib0034","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1182\/bloodadvances.2020001782","article-title":"Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"4","author":"Huang","year":"2020","journal-title":"Blood Adv"},{"issue":"18","key":"10.1016\/j.clml.2023.05.012_bib0035","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2009-07-231324","article-title":"Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation","volume":"115","author":"Sieniawski","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clml.2023.05.012_bib0036","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41409-018-0294-2","article-title":"High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI\/Cancer Research UK Phase II Study","volume":"54","author":"Phillips","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"13","key":"10.1016\/j.clml.2023.05.012_bib0037","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood-2012-11-466839","article-title":"Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT","volume":"121","author":"Jantunen","year":"2013","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1016\/j.clml.2023.05.012_bib0038","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/blood-2021-153709","volume":"138","author":"Sibon","year":"2021","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.clml.2023.05.012_bib0039","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","article-title":"Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01","volume":"30","author":"d'Amore","year":"2012","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.clml.2023.05.012_bib0040","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00277-019-03791-y","article-title":"Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"98","author":"Yi","year":"2019","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.clml.2023.05.012_bib0041","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ajh.23213","article-title":"Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group","volume":"87","author":"Tse","year":"2012","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.clml.2023.05.012_bib0042","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2023.05.012_bib0043","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clml.2023.05.012_bib0044","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41577-020-00452-4","article-title":"Silva-Santos B. gammadelta T cells in tissue physiology and surveillance","volume":"21","author":"Ribot","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.clml.2023.05.012_bib0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JOP.18.00594","article-title":"Hepatosplenic gamma-delta T-Cell Lymphoma: Who Is on Your Speed Dial?","volume":"15","author":"Krishnan","year":"2019","journal-title":"J Oncol Pract"},{"issue":"18","key":"10.1016\/j.clml.2023.05.012_bib0046","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.2019004118","article-title":"Hepatosplenic T-cell lymphoma: a rare but challenging entity","volume":"136","author":"Pro","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.05.012_bib0047","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.anndiagpath.2016.10.005","article-title":"Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-alpha inhibitor therapy and literature review","volume":"26","author":"Yabe","year":"2017","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"10.1016\/j.clml.2023.05.012_bib0048","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","article-title":"Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases","volume":"40","author":"Yabe","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.clml.2023.05.012_bib0049","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","article-title":"Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment","volume":"20","author":"Falchook","year":"2009","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clml.2023.05.012_bib0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3816\/CLML.2010.n.021","article-title":"Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review","volume":"10","author":"Ochenrider","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"10.1016\/j.clml.2023.05.012_bib0051","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.clml.2023.05.012_bib0052","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/j.clml.2023.05.012_bib0053","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2023.05.012_bib0054","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2023.05.012_bib0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.humpath.2015.11.010","article-title":"Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients","volume":"50","author":"Yabe","year":"2016","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.clml.2023.05.012_bib0056","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<61::AID-AJH10>3.0.CO;2-L","article-title":"Hepato-splenic gammadelta T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome","volume":"60","author":"Nosari","year":"1999","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.clml.2023.05.012_bib0057","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1309\/BM40-YM6J-9T3X-MH8H","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features","volume":"116","author":"Vega","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.clml.2023.05.012_bib0058","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.clml.2023.05.012_bib0059","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/leu.2014.200","article-title":"Frequent STAT5B mutations in gammadelta hepatosplenic T-cell lymphomas","volume":"28","author":"Nicolae","year":"2014","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.clml.2023.05.012_bib0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T-cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.clml.2023.05.012_bib0061","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clml.2012.09.002","article-title":"Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience","volume":"13","author":"Voss","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"10.1016\/j.clml.2023.05.012_bib0062","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2014.280","article-title":"Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party","volume":"29","author":"Tanase","year":"2015","journal-title":"Leukemia"},{"issue":"24","key":"10.1016\/j.clml.2023.05.012_bib0063","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1182\/blood-2011-12-396150","article-title":"Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets","volume":"119","author":"Travert","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2023.05.012_bib0064","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/annonc\/mdn119","article-title":"Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine","volume":"19","author":"Jaeger","year":"2008","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.clml.2023.05.012_bib0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2017-09-806737","article-title":"A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma","volume":"131","author":"Amengual","year":"2018","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.clml.2023.05.012_bib0066","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2023.05.012_bib0067","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000478-199101000-00002","article-title":"Jaffe ES. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome","volume":"15","author":"Gonzalez","year":"1991","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.clml.2023.05.012_bib0068","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2023.05.012_bib0069","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaad.2018.05.1243","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: clinical features, therapeutic approach, and outcome in a case series of 16 patients","volume":"79","author":"Lopez-Lerma","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.clml.2023.05.012_bib0070","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clml.2023.05.012_bib0071","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/DAD.0b013e31826b4b1a","article-title":"CCL5 expression in panniculitic T-cell dyscrasias and its potential role in adipocyte tropism","volume":"35","author":"Magro","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.clml.2023.05.012_bib0072","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41467-020-15572-7","article-title":"Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas","volume":"11","author":"Daniels","year":"2020","journal-title":"Nature Commun"},{"issue":"11","key":"10.1016\/j.clml.2023.05.012_bib0073","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous gammadelta T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.clml.2023.05.012_bib0074","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jamadermatol.2022.3347","article-title":"Clinical and pathological characteristics and outcomes among patients with subcutaneous panniculitis-like T-Cell lymphoma and related adipotropic lymphoproliferative disorders","volume":"158","author":"Guitart","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.clml.2023.05.012_bib0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.semdp.2016.11.009","article-title":"Cutaneous lymphomas with a panniculitic presentation","volume":"34","author":"Willemze","year":"2017","journal-title":"Semin Diagn Pathol"},{"issue":"23","key":"10.1016\/j.clml.2023.05.012_bib0076","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Rosee","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clml.2023.05.012_bib0077","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.clml.2023.05.012_bib0078","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/PAS.0000000000000596","article-title":"Useful parameters for distinguishing subcutaneous panniculitis-like T-cell lymphoma from lupus erythematosus panniculitis","volume":"40","author":"LeBlanc","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.clml.2023.05.012_bib0079","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/DAD.0000000000001173","article-title":"Subcutaneous panniculitis-like T-cell lymphoma versus lupus erythematosus panniculitis: distinction by means of the periadipocytic cell proliferation index","volume":"40","author":"Sitthinamsuwan","year":"2018","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.clml.2023.05.012_bib0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/PAS.0000000000000768","article-title":"Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (gammadelta) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous gammadelta T-Cell Lymphomas","volume":"41","author":"Merrill","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1-2","key":"10.1016\/j.clml.2023.05.012_bib0081","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s44228-022-00011-9","article-title":"Clinical, diagnostic and prognostic characteristics of primary cutaneous gamma Delta T-cell lymphomas","volume":"4","author":"Muhsen","year":"2022","journal-title":"Clin Hematol Int"},{"issue":"4","key":"10.1016\/j.clml.2023.05.012_bib0082","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1182\/bloodadvances.2018028340","article-title":"Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma","volume":"3","author":"Polprasert","year":"2019","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.clml.2023.05.012_bib0083","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"50","author":"Gayden","year":"2018","journal-title":"Nature Genet"},{"issue":"20","key":"10.1016\/j.clml.2023.05.012_bib0084","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1182\/bloodadvances.2021004562","article-title":"Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations","volume":"5","author":"Koh","year":"2021","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.clml.2023.05.012_bib0085","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cancergen.2012.05.006","article-title":"Comprehensive cytogenetic study of primary cutaneous gamma-delta T-cell lymphoma by means of spectral karyotyping and genome-wide single nucleotide polymorphism array","volume":"205","author":"Yamamoto-Sugitani","year":"2012","journal-title":"Cancer Genet"},{"issue":"12","key":"10.1016\/j.clml.2023.05.012_bib0086","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/jamadermatol.2016.3117","article-title":"Cutaneous gamma-delta T-cell lymphoma successfully treated with brentuximab vedotin","volume":"152","author":"Rubio-Gonzalez","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.clml.2023.05.012_bib0087","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.clml.2015.11.013","article-title":"A single-center experience with brentuximab vedotin in gamma delta T-cell lymphoma","volume":"16","author":"Talpur","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.clml.2023.05.012_bib0088","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaad.2015.01.003","article-title":"Hematopoietic stem cell transplantation for primary cutaneous gammadelta T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma","volume":"72","author":"Gibson","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"Supplement_1","key":"10.1016\/j.clml.2023.05.012_bib0089","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1182\/blood-2019-130223","article-title":"Characteristics, treatment patterns, and outcomes in primary cutaneous gamma delta T Cell Lymphoma (PCGDTCL): A real world multi-institutional analysis of a rare malignancy","volume":"134","author":"David","year":"2019","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.clml.2023.05.012_bib0090","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/cncr.28676","article-title":"Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network","volume":"120","author":"Herrera","year":"2014","journal-title":"Cancer."},{"issue":"18","key":"10.1016\/j.clml.2023.05.012_bib0091","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French lymphopath network","volume":"35","author":"Laurent","year":"2017","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.clml.2023.05.012_bib0092","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood.2022015854","article-title":"Genomic profiling for clinical decision making in lymphoid neoplasms","volume":"140","author":"de Leval","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.05.012_bib0093","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"189","article-title":"World Health Organization Classification of Tumours","author":"Jaffe","year":"2001"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023001702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023001702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:43:12Z","timestamp":1761871392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265023001702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":93,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2152265023001702"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2023.05.012","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2023.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}